TREATMENT WITH GLP-2 ANALOG TEDUGLUTIDE IN ACTIVE CROHN'S DISEASE AND SHORT BOWEL SYNDROME: STATE OF THE ART AND CASE REPORT OF THE FIRST ITALIAN EXPERIENCE

被引：0
|
作者：
Borghini, R. [1 ]
Caronna, R. [2 ]
Donato, G. [4 ]
Corazziari, E. S. [3 ]
Picarelli, A. [1 ]
机构：
[1] Sapienza Univ, Dept Internal Med & Med Specialties, Rome, Italy
[2] Sapienza Univ, Dept Surg Sci, Rome, Italy
[3] Humanitas Res Hosp, Rozzano, Italy
[4] Sapienza Univ, Dept Clin Med, Rome, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2019年 / 51卷
关键词：
D O I：
10.1016/S1590-8658(19)30193-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OC.10.5
引用
收藏
页码：E104 / E105
页数：2
相关论文
共 21 条
  • [1] Teduglutide - GLP-2 receptor agonist treatment of short-bowel syndrome treatment of Crohn's disease
    Revill, P.
    Mealy, N.
    DRUGS OF THE FUTURE, 2007, 32 (06) : 491 - 496
  • [2] GLP-2 analog Teduglutide in active Crohn's disease and short bowel syndrome: Confirmation of anti-inflammatory role and future perspectives
    Borghini, Raffaele
    Caronna, Roberto
    Donato, Giuseppe
    Picarelli, Antonio
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (06) : 686 - 687
  • [3] Teduglutide in Patients With Active Crohn's Disease and Short Bowel Syndrome
    Al Draiweesh, Saleh
    Ma, Christopher
    Gregor, James C.
    Rahman, Adam
    Jairath, Vipul
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (09) : E109 - E109
  • [4] Case Report: Morphologic and Functional Characteristics of Intestinal Mucosa in a Child With Short Bowel Syndrome After Treatment With Teduglutide: Evidence in Favor of GLP-2 Analog Safety
    Falco, Enrico Costantino
    Lezo, Antonella
    Calvo, Pierluigi
    Rigazio, Caterina
    Opramolla, Anna
    Verdun, Ludovica
    Cenacchi, Giovanna
    Pellegrini, Marianna
    Spada, Marco
    Canavese, Gabriella
    FRONTIERS IN NUTRITION, 2022, 9
  • [5] Teduglutide, a Novel Mucosally Active Analog of Glucagon-Like Peptide-2 (GLP-2) for the Treatment of Moderate to Severe Crohn's Disease
    Buchman, Alan L.
    Katz, Seymour
    Fang, John C.
    Bernstein, Charles N.
    Abou-Assi, Souheil G.
    INFLAMMATORY BOWEL DISEASES, 2010, 16 (06) : 962 - 973
  • [6] Teduglutide, a GLP-2 analog enhances intestinal structure in short bowel syndrome (SBS) patients dependent on parenteral nutrition (PN)
    Tappenden, Kelly
    Pertkiewicz, Marek
    Gilroy, Richard
    Allard, Johane
    Kunecki, Marek
    Sauerwein, Hans
    Mc-Graw, Nancy
    Bekker, Palle
    Messing, Bernard
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S105 - S105
  • [7] Impact of teduglutide, a GLP-2 agonist, on inflammatory bowel disease-associated short bowel syndrome: a tertiary single-center study
    de Seze, M.
    Billiauws, L.
    Bettolo, J.
    Damas, V.
    Hutinet, C.
    Bonvalet, F.
    Cazals-Hatem, D.
    Villain, C.
    Bouhnik, Y.
    Joly, F.
    Uzzan, M.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S454 - S455
  • [8] Further improvement after 24-month treatment with teduglutide in a patient with active Crohn's disease and short bowel syndrome
    Borghini, Raffaele
    Caronna, Roberto
    Corazziari, Enrico Stefano
    Picarelli, Antonio
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2018, 29 (02): : 249 - 250
  • [9] Teduglutide, a Human Recombinant Analog of Glucagon-Like Peptide-2 (GLP-2), Increases Plasma Citrulline Levels in Patients With Short Bowel Syndrome
    Messing, Bernard
    Joly, Francisca
    Schwartz, Lauren K.
    Iyer, Kishore R.
    Chu, Henry
    Youssef, Nader
    GASTROENTEROLOGY, 2012, 142 (05) : S369 - S369
  • [10] Teduglutide, a Recombinant Analog of GLP-2, Reduces Parenteral Support in Patients with Short Bowel Syndrome Regardless of Ultra-Short Remnant Bowel and/or No Colon-in-Continuity Anatomy.
    Fujioka, Ken
    Schneider, Stephane M.
    Li, Benjamin
    Youssef, Nader N.
    Pape, Ulrich-Frank
    Jeejeebhoy, Khursheed
    TRANSPLANTATION, 2015, 99 : S27 - S27
123